Matsunari I, Kinuya S, Nishikawa T, Matoba M, Murakita K, Ohguchi M, Ichiyanagi K, Taki J, Tonami N, Hisada K
Department of Radiology, Fukui Prefectual Hospital.
Ann Nucl Med. 1996 Feb;10(1):143-5. doi: 10.1007/BF03165069.
Technetium-99m tetrofosmin and thallium-201 lung SPECT imaging were performed in a patient with adenocarcinoma of the lung. Significant activities in the lung lesion were clearly depicted on both technetium-99m tetrofosmin and thallium-201 SPECT imaging. The early uptake, delayed uptake ratios and retention indices of the tumor were 2.75, 2.39 and -1.31 for thallium-201 imaging and 3.09, 2.27 and -26.5 for technetium-99m tetrofosmin imaging, respectively. This preliminary report suggests that technetium-99m tetrofosmin may have potential as a tumor imaging agent.
对一名肺癌腺癌患者进行了锝-99m替曲膦和铊-201肺部单光子发射计算机断层显像（SPECT）检查。在锝-99m替曲膦和铊-201 SPECT显像上均清晰显示出肺部病变中有明显放射性浓聚。铊-201显像时肿瘤的早期摄取、延迟摄取率和滞留指数分别为2.75、2.39和-1.31，锝-99m替曲膦显像时分别为3.09、2.27和-26.5。这份初步报告表明，锝-99m替曲膦可能具有作为肿瘤显像剂的潜力。
